By Mrs Kendal Jane Chidwick

Journal articles

Bharat C; Chidwick K; Gisev N; Farrell M; Ali R; Degenhardt L, 2024, 'Trends in use of medicines for opioid agonist treatment in Australia, 2013–2022', International Journal of Drug Policy, 123, http://dx.doi.org/10.1016/j.drugpo.2023.104255

Ahmed S; Pollack A; Havard A; Pearson SA; Chidwick K, 2023, 'Agreement of acute serious events recorded across datasets using linked Australian general practice, hospital, emergency department and death data: implications for research and surveillance', International Journal of Population Data Science, 8, http://dx.doi.org/10.23889/ijpds.v8i1.2118

Chidwick K; Pollack A; Busingye D; Norman S; Grulich A; Bavinton B; Guy R; Medland N, 2022, 'Utilisation of pre-exposure prophylaxis (PrEP) for HIV prevention in the Australian general practice setting: a longitudinal observational study', Sexual Health, 19, pp. 101 - 111, http://dx.doi.org/10.1071/SH21207

Pollack A; Busingye D; Thistlethwaite J; Blogg S; Chidwick K, 2022, 'Characteristics of patients aged 50-74 years with a request for an immunochemical faecal occult blood test in the Australian general practice setting', Australian Health Review, 46, pp. 222 - 232, http://dx.doi.org/10.1071/AH21129

Chidwick K; Myton R; Rodgers A; Jun M; Dartnell J; Balcomb A; Dore G, 2022, 'A cluster randomized controlled trial of a MedicineInsight Educational Quality Improvement Programme to improve the diagnosis and treatment of chronic hepatitis C in general practice (the EQUIP-HEPC trial)', Journal of Viral Hepatitis, 29, pp. 135 - 146, http://dx.doi.org/10.1111/jvh.13629

Daniels B; Havard A; Myton R; Lee C; Chidwick K, 2022, 'Evaluating the accuracy of data extracted from electronic health records into MedicineInsight, a national Australian general practice database', International Journal of Population Data Science, 7, http://dx.doi.org/10.23889/IJPDS.V7I1.1713

Havard A; Manski-Nankervis JA; Thistlethwaite J; Daniels B; Myton R; Tu K; Chidwick K, 2021, 'Validity of algorithms for identifying five chronic conditions in MedicineInsight, an Australian national general practice database', BMC Health Services Research, 21, pp. 551, http://dx.doi.org/10.1186/s12913-021-06593-z

Busingye D; Daniels B; Brett J; Pollack A; Belcher J; Chidwick K; Blogg S, 2021, 'Patterns of real-world opioid prescribing in Australian general practice (2013-18)', Australian Journal of Primary Health, 27, pp. 416 - 424, http://dx.doi.org/10.1071/PY20270

Busingye D; Chidwick K; Simpson V; Dartnell J; J Dore G; Balcomb A; Blogg S; Dore G, 2021, 'The changing characteristics of patients with chronic hepatitis C prescribed direct acting antiviral medicines in general practice since listing of the medicines on the Australian Pharmaceutical Benefits Scheme', JGH Open, 5, pp. 813 - 819, http://dx.doi.org/10.1002/jgh3.12593

de Oliveira Costa J; Gianacas C; Beard F; González-Chica DA; Chidwick K; Osman R; MacIntyre CR; Havard A, 2021, 'Cumulative annual coverage of meningococcal B vaccination in Australian general practice for three at-risk groups, 2014 to 2019', Human Vaccines & Immunotherapeutics, pp. 1 - 10, http://dx.doi.org/10.1080/21645515.2021.1923349

Busingye D; Pollack A; Chidwick K, 2021, 'Prevalence of inflammatory bowel disease in the Australian general practice population: A cross-sectional study', PLoS ONE, 16, pp. e0252458, http://dx.doi.org/10.1371/journal.pone.0252458

Belcher J; Myton R; Yoo J; Boville C; Chidwick K, 2021, 'Exploring the physical health of patients with severe or long-term mental illness using routinely collected general practice data from MedicineInsight', Australian Journal of General Practice, 50, pp. 944 - 951, http://dx.doi.org/10.31128/AJGP-08-20-5563

Schaffer AL; Busingye D; Chidwick K; Brett J; Blogg S, 2021, 'Pregabalin prescribing patterns in Australian general practice, 2012–2018: a cross-sectional study', BJGP Open, 5, pp. 1 - 10, http://dx.doi.org/10.3399/bjgpopen20X101120

Chidwick K; Busingye D; Pollack A; Osman R; Yoo J; Blogg S; Rubel D; Smith S, 2020, 'Prevalence, incidence and management of atopic dermatitis in Australian general practice using routinely collected data from MedicineInsight', Australasian Journal of Dermatology, 61, pp. e319 - e327, http://dx.doi.org/10.1111/ajd.13268

Totterdell J; Phillips A; Glover C; Chidwick K; Marsh J; Snelling T; Macartney K, 2020, 'Safety of live attenuated herpes zoster vaccine in adults 70–79 years: A self-controlled case series analysis using primary care data from Australia's MedicineInsight program', Vaccine, 38, pp. 3968 - 3979, http://dx.doi.org/10.1016/j.vaccine.2020.03.054

Busingye D; Gianacas C; Pollack A; Chidwick K; Merrifield A; Norman S; Mullin B; Hayhurst R; Blogg S; Havard A; Stocks N, 2019, 'Data Resource Profile: MedicineInsight, an Australian national primary health care database', International Journal of Epidemiology, 48, pp. 1741 - 1741H, http://dx.doi.org/10.1093/ije/dyz147

Chidwick K; Strongman H; Matthews A; Stanway S; Lyon AR; Smeeth L; Bhaskaran K, 2018, 'Statin use in cancer survivors versus the general population: Cohort study using primary care data from the UK clinical practice research datalink', BMC Cancer, 18, pp. 1018, http://dx.doi.org/10.1186/s12885-018-4947-8

Chidwick K; Kiss D; Gray R; Yoo J; Aufgang M; Zekry A, 2018, 'Insights into the management of chronic hepatitis C in primary care using MedicineInsight', Australian journal of general practice, 47, pp. 639 - 645, http://dx.doi.org/10.31128/AJGP-02-18-4482

Illingworth PJ; Lahoud R; Quinn F; Chidwick K; Wilkinson C; Sacks G, 2014, 'Single-arm, observational study of the ease of use of a redesigned pen device to deliver recombinant human follicle-stimulating hormone (follitropin alfa) for assisted reproductive technology treatment', Patient Preference and Adherence, 8, pp. 813 - 826, http://dx.doi.org/10.2147/PPA.S58046

Conference Papers

Havard A; Chidwick K; Daniels B; Thistlethwaite J; Myton R; Blogg S; Wall M; Quick L; Pollack A; Manski-Nankervis J-A, 2021, 'Validity of algorithms for identifying five chronic conditions in MedicineInsight, Australian national primary care data', in INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, OXFORD UNIV PRESS, http://dx.doi.org/10.1093/ije/dyab168.270

Reports

Chidwick K; Bharat C; Gisev N; Farrell M; Degenhardt L, 2023, NDARC Technical Report: Real-world dosing intervals of long-acting buprenorphine for opioid agonist treatment., UNSW Sydney, Sydney, 345, http://dx.doi.org/10.26190/ayet-f348, https://ndarc.med.unsw.edu.au/resource/real-world-dosing-intervals-long-acting-buprenorphine-opioid-agonist-treatment

Bharat C; Chidwick K; Gisev N; Farrell M; Degenhardt L, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in New South Wales, 2013-2022, UNSW Sydney, Sydney, 347, http://dx.doi.org/10.26190/rzmn-a864, https://ndarc.med.unsw.edu.au/resource/nsw-trends-use-opioid-agonist-treatment-australia-2013-2022

Bharat C; Chidwick K; Gisev N; Farrell M; Degenhardt L, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in Queensland, 2013-2022, UNSW Sydney, Sydney, 349, http://dx.doi.org/10.26190/ybm1-3f83, https://ndarc.med.unsw.edu.au/resource/qld-trends-use-opioid-agonist-treatment-australia-2013-2022

Chidwick K; Gisev N; Degenhardt L; Farrell M; Bharat C, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in South Australia, 2013-2022, UNSW Sydney, Sydney, 350, http://dx.doi.org/10.26190/y21d-yd24, https://ndarc.med.unsw.edu.au/resource/sa-trends-use-opioid-agonist-treatment-australia-2013-2022

Chidwick K; Gisev N; Degenhardt L; Farrell M; Bharat C, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in Tasmania, 2013-2022, UNSW Sydney, Sydney, 351, http://dx.doi.org/10.26190/q6zj-fx75, https://ndarc.med.unsw.edu.au/resource/tas-trends-use-opioid-agonist-treatment-australia-2013-2022

Bharat C; Chidwick K; Gisev N; Farrell M; Degenhardt L, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in the Australian Capital Territory, 2013-2022, UNSW Sydney, Sydney, 346, http://dx.doi.org/10.26190/16m9-6z16, https://ndarc.med.unsw.edu.au/resource/ndarc-technical-reports-345-353

Bharat C; Chidwick K; Gisev N; Farrell M; Degenhardt L, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in the Northern Territory, 2013-2022, UNSW Sydney, Sydney, 348, http://dx.doi.org/10.26190/mt8r-kd57, https://ndarc.med.unsw.edu.au/resource/nt-trends-use-opioid-agonist-treatment-australia-2013-2022

Chidwick K; Gisev N; Degenhardt L; Farrell M; Bharat C, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in Victoria, 2013-2022, UNSW Sydney, Sydney, 352, http://dx.doi.org/10.26190/gjpp-py45, https://ndarc.med.unsw.edu.au/resource/vic-trends-use-opioid-agonist-treatment-australia-2013-2022

Chidwick K; Gisev N; Degenhardt L; Farrell M; Bharat C, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in Western Australia, 2013-2022, UNSW Sydney, Sydney, 353, http://dx.doi.org/10.26190/ftbz-w461, https://ndarc.med.unsw.edu.au/resource/wa-trends-use-opioid-agonist-treatment-australia-2013-2022

Back to profile page